ketoconazole has been researched along with alisporivir in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexander, N; Barve, A; Einolf, H; Gu, H; Hanna, I; He, H; Heimbach, T; Ke, J; Mangold, JB; Sunkara, G; Wang, L; Xia, B; Zhang, T | 1 |
| Barve, A; Crabbe, R; Dabovic, K; Dole, K; Grosgurin, P; Ke, J; Kovacs, SJ; Menetrey, A; Nicolas-Métral, V; Praestgaard, J; Stein, D; Sunkara, G; Zhang, J | 1 |
1 trial(s) available for ketoconazole and alisporivir
| Article | Year |
|---|---|
The effects of CYP3A4 induction and inhibition on the pharmacokinetics of alisporivir in humans.
Topics: Area Under Curve; Azithromycin; Belgium; Biotransformation; Cross-Over Studies; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Florida; Half-Life; Humans; Immunosuppressive Agents; Ketoconazole; Male; Metabolic Clearance Rate; Models, Biological; New York; Rifampin; Substrate Specificity | 2015 |
1 other study(ies) available for ketoconazole and alisporivir
| Article | Year |
|---|---|
Physiologically based pharmacokinetic modeling for assessing the clinical drug-drug interaction of alisporivir.
Topics: Administration, Oral; Caco-2 Cells; Cyclosporine; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Drug Interactions; Humans; Ketoconazole; Models, Biological; Rifampin | 2014 |